Index

Abdomen, acute, 98-99 Abdominal pain, 69, 107, 127,

169 and ovarian tumors, 169 and renal colic, 127

Abdominal pregnancy, see Pregnancy, ectopic

Abortificient substances, 74 Abortion,

and ovarian tumors, 175 stigma, 42

Abortion, induced, 5-6, 25-38, 50

availability, 27 contraindications, 30 counseling, 29 effect on fertility, 38 illegal,45 incidence, 25-26 mortality, 26 pharmacologic, 29 therapeutic, 160, 180

Abortion, legalization of, 44 Abortion, septic, 40-55

clinical manifestations, 44-48

diagnosis, 48-50 microbiology, 43-44 surgical management, 51 treatment, 50

Abortion, spontaneous, 13-14, 102

and coumarin derivatives, 194

in kidney transplant pa­tients, 180

multiple, 7 second trimester, 2-3, 5, 8 trauma, 147-148

Abruptio placentae, 143, 143-144

Abscesses, appendiceal, 110 Abscesses, intraabdominal,

drainage, 121-122 Accouchement force, see Dila-

tion, cervical Acetylsalicylic acid, 54, 194 Acidotic, 53 ACTH, 47, 88-89

ectopic production, 89-90 Adenocarcinomas, 160 Adenosis, vaginal, 4 Adenosquamous carcinomas,

160 Adler's sign, 108 Adnexal masses, 29; see also

Ovarian tumors Adrenal cortex, control, 88 Adrenalectomy, 90-92 Adrenal gland tumors, 87-89

virilizing, 96 Adrenocortical hyperplasia, 90 Adrenocortical insufficiency, 91 Adrenocortical steroids, 91 Adrenocortical tumors, see AI-

dosteronoma; Pheochro­mocytomas

Adrenocorticotropin hormone, see ACTH

Airway, maintenance/restora­tion, 137,138

Aldosteronoma, 91

Italicized page numbers indicate figures or tables on page.

Alkaline phosphatase assay, 155

alpha-adrenergic blockade, 94 alpha-adrenergic effects, 52 Amenorrhea, 68 Amniocentesis, 142 Amnioinfusion, 34, 37 Amnionitis, 7,17-20,49,186 Amniorrhexis, see Fetal mem-

branes Amniotic sac, bacterial contam-

ination,43 Amoxicillin, 36 Ampicillin, 53, 131-132 Amylase (serum), 101 Androgens, excess, 175 Anemia,

physiologic, 136 profound, 30

Anerobes, see Bacteria, aner­obic

Anesthesia, 11, 30-31, 157 general, 34, 158

mortality, 26 Anorexia, 107 Antenatal care, 165, 168 Antibiotics, 9, 50, 58

intravenous, 36 prophylactic, 16, 18, 20, 30,

42 contraindications, 102

therapy, 50,129 Anticoagulants, 193-194, 198

and SPT, 58 Antirejection treatment, see

Immunosuppressants

201

202

Antithyroid antibodies, 80 Antitrophoblastic substances,

74 Appendectomy, 113-114 Appendicitis, acute, 105-114

pathology, 105-106 treatment, 109-110

Appendix, displacement of, 105,106 ruptured, 110

Arachidonic acid, 6 Aspiration, needle, 155, 157 Aspirin, see Acetylsalicylic acid Azathioprine, 180, 186

Bacteremia, 40, 45 placental, 18

Bacteria, anaerobic, 44, 57 gram-negative, 50, 57 gram-positive, 44, 57 mixed (aerobic/anaerobic),

50,56,59 Bacterial flora, cervicovaginal,

20; see also Vagina, bac­terial flora

Bacteriuria, 109, 131 Bacteroides fragilis, 44, 50, 57 Bacteroides sp., 44, 50, 53, 57 Bed rest, 9, 13 BEP, 174 Beta-adrenergic agonists, 16 Beta-adrenergic blockade, 94 Beta-adrenergic effects, 52 Beta-endorphins, 47, 54 Beta human chorionic gonado­

tropin see BhCG Beta-lactamase enzymes, 44 Beta-mimetic agents, 14, 16,

102 effects, 52

BhCG, 64, 74 measurement, 69

Bierer forceps, 34 Biopsy,

breast, 155, 157 cervical lesion, 159 needle, 83, 180 thyroid,83

Birth weight, 18, 38 Bleeding,

intraabdominal, 144 vaginal, abnormal, 159, 169

Bleomycin, etoposide, cis­platim, see BEP

Blood loss, 74, 98-99 Blood volume, see Hemody­

namic abnormalities, and septic shock

Bone disease, metabolic, 86 Bowel,

obstruction, 121 resection, 117

Bowel disease, inflammatory, see IBD

Bradycardia, 33 Breast cancer, 154-155, 158

surgery, 155-157 Breathing, treatment of im­

paired, 138-139, 139 Bryan's sign, 108

Cachectin, 47, 54 Calcitriol, 126 Calcium (serum), 84, 86 Calcium (urinary), 84 Calcium homeostasis, 85 Calvaria removal, 36 Cannulas,

Karman-type soft, 28 suction, 32

Cardiac injury, penetrating, 140

Cardiac prosthetic valves, and pregnancy, 193-200

case studies, 195-199,197-199

complications, 196,197-199

neonate management, 196 Catecholamines, 92-94 Catheters,

Foley, 141-142 stent, 132

C-cell hyperplasia, 92 Centers for Disease Control, 26,

34,41 Cephalosporins, 131 Cerclage, 2-3, 19-21

complications, 17-19 contraindications, 19-20 perinatal mortality, 14 postoperative care, 15-16 procedures, evaluation of,

13-15 prophylactic, 4-5

transabdominal, 11-13 transvaginal, 10-11

Index

and uterine contractions, 14 Cervical dilation and curettage,

see D&C Cervical dystocia, 17 Cervical incompetence, 1-7,

19-21 diagnosis, 6--8 etiology, 3 incidence, 2 treatment, 8-9

surgical,9-13 Cervical lacerations, 36; see

also Cervix, trauma to Cervical os, internal, 1,4, 10,35

measurement, 8 Cervix,

carcinoma of, 5, 159-163 diagnosis, 159-160 FIGO staging classifica­

tion, 160 five-year survival,

162-163 incidence, 159 incidence by stage, 160 management, 161-162 microinvasive, 163 prognosis, 163

length,8 microbiology, 20, 43 patulous, 7 trauma to, 4-8

Cesarean hysterectomy, 17 Cesarean section, 12, 14-15,94,

163; see also Delivery, mode of

during appendectomy, 110 and kidney transplant pa­

tients, 185 and peptic ulcer, 99 trauma, 147

Chemotherapy, 155, 174 Chlamydia, 30 Chlamydia trachomatis, 42-43,

56 Chloroprocaine, 31 Cholecystitis, 99-100 Cholelithiasis, 99-101 Cholestectomy, 100 Chorioamnionitis, see Amnio-

nitis Choriocarcinoma, 82, 182 Chorionic villi, 29

Index

Chrondrodysplasia punctata, 194

Ciprofloxacin, 36 Circulation,

impaired, treatment of, 140 of trauma patient, 139-141

Clindamycin, 53 Clondine supression test, 94 Clostridial septicotoxemia syn-

drome, 44, 49, 55 Clostridium perfringens, 44,

48-49,55 Clotting time, 59 Coagulation, 54, 56 Coagulation, diffuse intravas-

cular, see DIC Coitus, following cerclage, 16 "Cold shock", 47 Colectomy, and ileostomy, 120 Colitis, ulcerative, 115-119

acute, 120-121 Collagenase, 2 Colon cancer, 115 Complement activation, 45 Computed tomography, see CT

scanning Congenital malformations, and

immunosuppressants, 186

Conization, 5, 8, 163 Contraction stress test, 183,184 Cornual gestation, 73-74 Corticosteroids, 117, 180

effect on fetus, 119 high dose, 54 prophylactic, 161

Cortisol, 89, 91 Cortisone, 91 Coumarin derivatives, 193-

196, 199 Counseling,

abortion, 29, 33 family planning, 189-190,

200 Crohn's disease, 115-116

newly diagnosed, 118-119 and prematurity, 116-118 surgical procedures, 121-122

Crystallography, 130 CT scanning, 51, 58, 89, 94, 142,

144 Culdocentesis, 36, 70, 142 Cullen sign, 101 Curettage, see D&C

Curettage, suction, 31-32; see also D&E

Cushing syndrome, 87-91 fetal mortality, 88-89 pituitary-adrenal axis, 88 signs and symptoms, 88 treatment, 90-91

Cyclosporine, 187-188 Cystadenomas, 166 Cystinuria, 131 Cystitis, 181 Cystoscopy, 128, 160 Cysts, 166

ovarian, 169 Cytotoxic drugs, 119

Dalkon Shield, 43 D&C, 25, 38, 50

complications, 30 first-trimester, 29-30 retained fetal tissue, 53

D&E, 25-26, 37-38, 41 complications, 36-37 instruments, 32 procedure, 31-33 second trimester, 33-36

infection incidence, 42 instruments, 35

Decidua formation, 9 Delivery, mode of, 163, 184-

185, 195, 199-200 Dennison dilators, 32, 34 Dermoid tumors, 166 DES exposure, 3-4, 8, 68 Dexamethasone suppression

test, 89 Diabetes, insulin-dependent,

30 Diagnostic peritoneal lavage,

see DPL Diarrhea, 108 DIC,48-50,54,144 Diethylstilbestrol, see DES ex-

posure Diffuse intravascular coagula­

tion, see DIC Digoxin, 53 Dilation, cervical, 1-2, 6-8

laparoscopic observation, 35 ultrasound guidance, 32

Dilators, 6-7, 32, 34; see also Laminaria

Dipridamole, 194

Dopamine, 52-53 Doxycycline, 30, 36 D-penicillamine,131

203

DPL, 141-142, 144-146 Drug and alcohol intake, 101 Dsyuria, 107 Dysgerminomas, see Germ cell

tumors

Echography, 165, 176 Eclampsia, see PreeclampsiaJ

eclampsia Ectropion, 4 Elastin, 2 Electrocardiograph, pregnancy

changes, 136 Endocarditis, subacute bacte­

rial, see SBE Endocrine glands, surgical dis­

eases, during pregnancy, 78-96

Endometritis, 36, 50 postabortion, 42 postpartum, 55

Endomyometritis, 186 Endosalpinx, alterations of, 66 Endoscopy, gastrointestinal, 98 Endotoxic shock syndrome, 40,

44-45,51 Endotracheal tubes, 26 Enterobacter, 44 Enterobacteria, gram-negative,

57 Enterobacteriaceae antibody,

54 Enterococcus, 53 Epinephrine, 92 Episiotomy, 185 Epithelial carcinomas, 174 Epostane, 29 Escherichia coli, 19, 44, 50,

53 Estrogens, 2, 6 Exophthalmos, 80

Factors V,50 VII,45 VIII,50 XII,45

Falope ring, 68 Fertilization, in vitro, 68

204

Fetal heart rate, 111, 183, 196; see also Tachycardia, fetal

recording of, 183-184, 185 Fetal injury, trauma, 146-147 Fetal maturity, 16-17; see also

Gestational age Fetal membranes,

premature rupture of, 2, 7, 10,17-19, 144, 182,185

spontaneous rupture of, 33 Fetal monitoring, 141, 183-184 Fetal tissues, retained, 36, 42-

43,50--51 Fetal weight, 161 Fever, 108

unexplained, 57 Fibroadenomas, 155 FIGO, staging classification,

160 Flail chest, 139 Florinef,91 Fluid replacement, 52 Folate, intestinal absorption,

119 Fractures, pelvic, 144 Free thyroxine index (T7), 78-

80

Gallbladder disease, see Chole-cystitis

Gastrectomy, subtotal, 99 Gastroduodenal perforation, 99 Gentamicin, 53 Germ cell tumors, 174-175 Gestation, length of, 29, 31, 66 Gestational age, 16-18,42 GFR, 126, 179 Glassy cell carcinomas, 160 Glomerular filtration rate, see

GFR Glucocorticoid,

production, 87 replacement, 91

Glucose metabolism, 182 Goiter, diffuse toxic, see Graves

disease Gonadal stromal tumors, 175 Gonadotropin, human chori­

onic, see hCG Gonorrhea, 30, 42 Graft rejection, 179, 187-188

postpartum, 186

pregnancy termination, 185-186

treatment of, 188-189 Granulosa cell tumors, 175 Graves disease, 79-82

neonatal,81-82 signs and symptoms, 80 treatment regimens, 81

Grey Turner sign, 101 Gunshot wounds, 144-145

upper abdomen, 145 uterus, 145

Hageman factor (factor XII), 45 hCG, 78, 82

titers, 29 hCT, 78, 82 Heart disease, cyanotic, 30 Hegar dilators, 6-7 Hemodynamic abnormalities,

and septic shock, 51-52 Hemorrhage, 98

acute, 121 control, 140

Heparin, 194, 196, 199 diagnostic, 58 therapy, 51, 55, 59

Hepatitis B, 181, 186 Hepatorenal syndrome, 48 Hepatorrhapy, 101 Heptic rupture, 100--101 Herpes, 181

genital,20 Histamine release, 46 Hodge pessary, 8-9 Hulka clip, 68 Hypercalcemia, 84, 86, 187 Hypercalciuria, 126, 131-132 Hyperemesis gravidarum, 86 Hyperestrogenism, 175 Hyperglycemia, 94 Hyperlipidemia, 101 Hyperparathyroidism, 83-87,

92, 101 maternal, 86-87, 87

complications, 86 diagnosis and treatment,

86-87 signs and symptoms, 85

Hypertension, and kidney transplant, 180--181

Hyperthyroidism, trophoblastic tumors, 82

Index

Hypertriiodothyroninemia, postnatal, 81

Hypocalcemia, 187 neonatal, 87

Hypoglycemia, fetal, 130 Hyponatremia, fetal, 130 Hypoparathyroidism, neonatal,

permanent, 86 Hypophosphatemia, 84 Hypotension, 33 Hypothyroidism, 79, 81 Hypoventilation, 27 Hypovolemia, 52 Hypoxemia, 53 Hypoxia, 27 Hysterectomy, 41, 174

abdominal, 38 extrafascial, 162 radical, 162 total,74 vaginal,37

Hysterosalpingography, 3, 7, 73 Hysterotomy, 37, 41, 43

IBD,115 effects of pregnancy on, 118 fertility, 115-116 fetal complications, 119-120 medical management, 119 quiescent, 116-117 surgical treatment,

120--122 Ileoanal anastomosis, 122 Ileostomy, 120, 122 I -metaiodobenzy 19uanidine

scanning, see MIBG scan­ning

Immunosuppressants, 178, 180--182

connective tissue laxity, 185 during pregnancy, 189 and high malignancy risk,

190 Incompetent cervix, see Cervical

incompetence Indomethacin, 54

effects on fetus, 16, 130 Infection,

clostridial, 55 extrauterine, 51 gram-negative, 44

nosocomial, 40 intracervical, 13, 19

Index

intrauterine, 20, 56 fetal,19

in kidney transplant pa­tients, 181

pelvic, 59, 66-67; see also Thrombophlebitis, septic pelvic

and ectopic pregnancy, 65 postabortion, 41, 44, 67

antibiotic regimens, 50 etiology, 42 pathogenesis, 42 treatment, 53

postoperative, 17-18 vaginal,20

Inferior vena cava, see Ive ob­struction

Infertility, secondary, 67 International Federation of Gy­

necology and Obstetrics, see FIGO, staging classi­fication

Intrauterine device, see IUD Intrauterine (fetal) growth re­

tardation, see IUGR Iodide, 81-82 Isotope scans, contraindication,

78,82,89 Isoxsuprine, 176 Isthmic gestation, 74 Isthmus,

cervical, 6-7 funneling, 7

Isthmus of Aschoff, 2 IUD, 43, 48, 64, 189-190

and ectopic pregnancy, 67 IUGR, 181-182 Ive obstruction, 135, 141,

144

Kallikrien activation, 45 Kernicterus, 119 Kidney stones, see Renal calculi Kidney transplants,

complications of, 178 effect of pregnancy, 179

Kidney transplants, and preg­nancy, 178-190

complications, 180-183, 186

maternal deaths, 185-186 planning, 189-190

Klebsiella, 44, 50

Labor and delivery, complica-tions of, 17

Labor,induced,184 Lamicel dilators, 33 Laminaria, 30, 33-34, 41

D&E,37 tents, 6

Laminaria japonicum, 33 Laparoscopy,37

diagnostic, 29, 70-71 observation, 35

Laparotomy, 51, 121 exploratory, 57, 141, 145-

146,146 Laser conization, 5 Leiomyomas, submucous, 7 Leukocytosis, 109 Leukopenia, 187 Lidocaine 1%, 31 Ligaments, 11 Lithotomy, open, 131 Lithotomy position, 10

dorsal,34 Lithotripsy, 132 Luteoma of pregnancy, 173 Lymphadenectomy, 162 Lymphocytosis, 80

Magnetic resonance imaging, see MRI scanning

Mammography, in pregnancy, 155

Manchester Fothergill opera-tion, 11

Mastectomy, 156 MAST suit, 52, 141 McDonald procedure, 11, 15, 18 Medicolegal considerations,

abortion/trauma, 147-148

MEN-IIa, 83, 94 MEN-lIB, 83, 84 MEN-II syndromes, 92

characteristics of, 83 Menstrual,

cycle, 6 extraction, 28

Meperidine, contraindications, 130

6-mercaptopurine, 119 Mersilene sutures, 11-12 Metanephrine, 93 Metastases, systemic, 155, 158

Methimazole, 81 Methotrexate, 74 Methylergonovine (Mether-

gine),36 Metronidazole, 120

205

MIBG scanning, 94 Microadenoma, transphenoidal

resection, 90 Mifepristone (RU 486), 29 Minocycline, 30 Mitral valve prolapse, 30 Morphine, contraindications,

130 MRI scanning, 89, 94 Multiple endocrine neoplasia,

see MEN-IIa; MEN-lIB; MEN-II syndromes

Myocardial contusion, 139 Myometrial activity, 15

abnormal,3 Myometrium, infection, 51 Myxedema, pretibial, 80

Nasogastric tube, 141 Nausea, 107 Neisseria gonorrhoeae, 42-43,

56 Neonatal, mortality and mor­

bidity, 186-187 Neonate survival, and cervical

carcinoma, 161 Nephrocalcin, 132

excretion of, 126 Nephrolithiasis, 86; see also Re­

nal calculi presentation, 127

N ephrostomy, percutaneous, 128, 131

Neurofibromatosis, 92-93 Nitrofurantoin, 131 Nitrous oxide, 11 Norepinephrine, 92 Nutrition, total parenteral, see

TPN

Ob/Gyn residents, and abortion, 27

Obstruction, appendiceal, 105-107 ureteral, 128

Omentectomy, 174 Omnopon,16

206

Oophorectomy, 172 Oral contraceptives, 190,200

and cholelithiasis, 99 Orciprenaline, 102 Ovarian cancers, 173-175

classification of stages, 170 histologic subtypes, 167, 174-

175 survival rates, 173

incidence, 166--167 presentation and diagnosis,

169 prognosis, 169

Ovarian function, 178 Ovarian tumors, 165-176

by gestational age, 168 histologic subtypes, 167 incidence, 165-168,166 malignant, see Ovarian can-

cers management, 170-171, 171 pregnancy outcome, 175 presentation and diagnosis,

168-169 spontaneous resolution, 166,

168, 172-173 surgical management, 168,

172 delay, 176 fetal wastage, 175

virilizing, 173 Ovarian vein thrombosis, 57-

58 Ovaries,

adnexal masses, 165 resection, 172

Ovulation, induction of, 68 late, 68

Ovum transmigration, 68 Oxytocin, 15, 36

Pain, abdominal, 69, 107, 127, 169

Pancreatitis, 86, 101-103 Paracervical block, 30-33; see

also Anesthesia Parathroidectomy,86 Parathyroid glands, carcinoma

of,84 Parathyroid hormone, see PTH Parathyroid hyperplasia, 92 PAS, 36 PAWP,52

PCWP,53 PDR,131 Pelvic inflammatory disease,

see PID Peptic ulcer disease, 98-99 Peptostreptococcus, 44, 50, 53,

57 Pericardial tamponade, 140 Peritonitis, 108 Pessary, 8-9 Phenoxybenzamine 96; see also

alpha-adrenergic block­ade

Pheochromocytomas, 92-95 diagnosis, 93-94 extraadrenal, 95 malignant, 95-96 signs and symptoms, 93

Phosphate, urinary, 84 Phosphate therapy, 87 Physician's Desk Reference, see

PDR PID,67 Pituitary,

adenoma, 88-89 irradiation, 90

Placental separation, 143-144 Placental transfer, 78, 85, 194-

195 Placental villi, see Chorionic

villi Placentation, abnormal, 7 Plasma, fresh frozen, 195, 197,

199 Pneumatic anti-shock garment,

140 Pneumatic trousers, see MAST

suit Pneumocystis carnii, 181 Pneumothorax, 138-139

tension, 138, 139 Pomeroy operation, 67 Post abortion syndrome, see

PAS Pratt dilators, 32, 34 Prednisone, 119, 186 Preeclampsia/eclampsia, 100-

102,180 Pregnancy,

effects on renal calculi, 129 heterotopic, 70, 72 loss of, see Abortion, sponta­

neous multiple, 30

and cerclage, 17-18

Index

physiologic changes, 132 cardiovascular, 135-136 gastrointestinal, 136 hematologic, 136 hormonal, 6, 136 renal, 136-137 respiratory, 136

planning, 189-190, 200 termination of, see Abortion,

induced Pregnancy, ectopic, 28-30, 38,

182 diagnosis, 69-71 epidemiology, 64-66 etiology, 66-68 frequency, 65 management, 73-74 maternal mortality, 65, 66,

72 nonintervention, 74 repeated, 73 signs and symptoms, 68-69 sites, 71-72

Premature delivery, 13, 19, 38, 113, 117, 182

Premature labor, 102, 112-113 heart rate, 112-113 prevention, 110-111 and renal colic, 129

PRM, see Fetal membranes, premature rupture of

Proctocolectomy, 122 Proctoscopy, 160 Progestational agents, 16, 176 Progesterone, 2, 6

increased, 98 Progestin therapy, 9 Propranolol, 81-82, 96; see also

Beta-adrenergic blockade Propylthiouracil, see PTU Prostaglandins, 2, 6,15; see also

Arachidonic acid intraamniotic injection, 41 serum, 15-16 synthetase inhibitors, 16, 54

Proteinuria, 179, 181 Proteus sp., 50 Prothrombin time, 195-196

and fresh frozen plasma, 199 Pseudomonas, 181 Psychiatric disorders, 86 Psychosocial considerations,

Abortion/trauma, 148 PTH, 84-85, 126 PTU,81-82

Index

Pulmonary artery wedge pres­sure, see PAWP

Pulmonary emboli, septic, 56, 58

Purine metabolism, 131 Pyelogram, 160 Pyelonephritis, 109, 181

and calculous disease, 129 refractory to antibiotics, 128

Pyloroplasty, with truncal va­gotomy,99

Radiation therapy, 162, 174 Radiography, 141 Radioiodine therapy, 83 RDS, 53,186 Reactive nonstress test, 183 Relaxin, 2 Renal calculi, 125-132

diagnosis, 127-128 etiology, 125-127 intervention, 129 management, 130 postpartum evaluation, 130 spontaneous passage, 128 surgery, 131 types, 127

Renovascular dysfunction, 178 Respiratory distress syndrome,

see RDS Respiratory failure, 53 Rh-negative, 30 Ritodrine, 16, 102, 111

and fetal tachycardia, 112

Salbutamol, 16 Saline, intraamniotic injection,

42 Salpingectomy, 73 Salpingitis, 66 Salpingo-oophorectomy, 73-74,

174-175 Salpingo-oophoritis, 66-67 Salpingostomy, 73-75 SBE, 196, 200 Seat belts, during pregnancy,

148-149 Secundines, retained, 30 Seizure disorders, 30 Sella turica, 89 Sepsis, see Infection Septicotoxemia, clostridial, 44,

49,51

Septic shock, see Shock, septic Sertoli-Leydig tumors, 175 Shirodkar operation, 10-12, 18,

20 Shock, see also Endotoxic shock

syndrome; Toxic shock syndrome

hemorrhagic, 140 septic, 40,46

mortality with, 41 pathophysiology, 45, 46,

47-48 signs and symptoms, 49-50 treatment, 50, 53-54

Shock trousers, see MAST suit Sims sound, 32-33 Sonography,

diagnostic, 69-70, 165 intravaginal, 70

Sopher forceps, 34, 35 Squamous carcinomas, 160 Stab wounds, abdominal, 146 Staphylococcus, 181 Staphylococcus aureus, 19, 44,

50, 53 Statistical methods, 14 Sterilization, 37-38, 196, 200

laparoscopic, 67-68 Streptococcus (Group B), 19, 50,

53 Streptococcus, Beta-homolytic

(Group A), 42-43, 56 Struvite kidney stones, 126 Sulfasalazine, 117, 119 Sulfonamides, 131 Surgery,

exploratory, 58 transabdominal, 11-13 transvaginal, 9-11

Sutures, 10-11, 19

Tachycardia, 108 fetal, 81-82, 112

TBG,78 Tc-IDA scanning, 100, 102 Tenaculum tears, 36 Tenderness, abdominal, 108 Teratomas, 166 Terbutaline, 102 Tetany, neonatal, 86-87 Tetracycline, 30, 33 Thiazides, contraindications,

130-131 Thionamide drugs, 81

207

Thiopental, 11 Thoracoabdominal stab

wounds, 146 Thrombocytopenia, 181, 187

fetal,130 Thromboembolic complications,

199 Thrombophlebitis,

septic pelvic, 40, 50-51, 55-58, 186

etiology, 56-57 Thromboplastin time, partial,

195 Thromboxane, 15 Thyroid,

cancer, diagnosis, 82-83 medullary, 92

disease, 78-87 dysfunction, transient post­

partum,82 function tests, 79 hormones, placental transfer,

78 nodules of, 82-83 parenchyma, lymphoid infil­

tration,80 Thyroidectomy, subtotal, 81 Thyroid-stimulating hormone,

see TSH Thyroid-stimulating immuno­

globulins, see TSIs Thyrotoxicosis, 80

maternal, 79, 81 trophoblastic, 82

Thyrotropin, human chorionic, see hCT

Thyroxine (T4), 78 Thyroxine-binding globulin, see

TBG Thyroxine therapy, 81, 83 Tocolytic agents, 9, 13-15, 110-

113 Tocolytic therapy, 129 Torsion, and ovarian tumors,

169,172 Toxic shock syndrome, 44 TPN,120 Tracheostomy, 137 Trauma management, 135

blunt abdominal injuries, 142

penetrating wounds, 144-146 standard ABC protocol, 137-

141

208

Trauma patient, pregnant, 135-149

diagnostic tests, 141-142 Trendelenburg tilt, 10 Triiodothyronine, bound (T3),

78 Trophoblastic disease, 182 Trophoblastic tumors, and hy-

perthyroidism, 82 TSR, 78-80, 83 TSIs,81 Tubal ligation, see Sterilization Tubal pregnancy, 71 Tubal surgery, 67-68 Tumor cytoreduction, 174

Ultrasonography, 7-8, 29-30 during D&E, 36 ectopic pregnancy, 64 mode B, 83 renal,127

Urease enzyme, 126 Ureteral peristalsis, 125 Urinary tract infection, see UTI Urine, 126 Urograms, excretory, 127-128

Uterine contractions, 111, 196 and cerclage, 14 recording of, 183-184, 185

Uterine irritability, 15 Uterine perforations, 30 Uterine relaxants, see Beta-mi-

metic agents Uterine rupture, 143, 143 Uteroscopy, rigid, 131-132 Uterus,

bicornate, 3, 29-30 and DES exposure, 3 didelphic, 3 evacuation, 101 perforation, 37, 42, 45, 51 retroverted, 30 septate, 3 size, 15,30

UTI, 107, 109, 129

VAC, 174 Vacuum aspiration, 6, 29; see

also D&E Vagina, bacterial flora, 20, 43,

56 Vagotomy, 99

Index

Valves, prosthetic, 193, 195-196, 199

dysfunction, 199 Vancomycin, 53 Vanillylmandelic acid, see

VMA VBP, 174 Veins, pelvic, ligation of, 58-59 Venography, 58 Villi, chorionic, see Chorionic

villi Vinblastine, bleomycin, cis­

platin, see VBP Vincristine, actinomycin D, cy­

clophosphamide, see VAC

Virilizing tumors, 96, 173 Vitamin D, metabolites, 86 Vitamin K, 193, 195-196, 199 VMA,93 von Rippel-Lindau disease, 93

Warfarin, 59, 180 Warfarin embryopathy, 193-

194, 197 "Warm shock", 46